Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

galderma (uk) ltd - amorolfine hydrochloride - medicated nail lacquer - 5 %w/v - amorolfine

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

galderma international - amorolfine - medicated nail lacquer - 5 percent weight/volume - other antifungals for topical use; amorolfine

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

galderma (uk) ltd - amorolfine hydrochloride - medicated nail lacquer - 50mg/1ml

Kenya - Kiingereza - Pharmacy and Poisons Board

asence pharma private limited sarabhai campus dr. vikram sarabhai marg wadi - diclofenac sodium - gel - diclofenac sodium 1% w/w in a gel - non-steroidal

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

galderma benelux b.v. - amorolfine hydrochloride 64 mg/g - eq. amorolfine 50 mg/g - medicated nail lacquer - 5 % - amorolfine hydrochloride 64 mg/g - amorolfine

Afrika Kusini - Kiingereza - South African Health Products Regulatory Authority (SAHPRA)

mylan pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains darunavir ethanolate 400,0 mg ritonavir 50,0 mg

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - ondansetron 4mg;   - orodispersible tablet - 4 mg - active: ondansetron 4mg   excipient: aspartame colloidal silicon dioxide crospovidone microcrystalline cellulose and guar gum (avicel ce15) strawberry flavour (gurana powder) isopropyl alcohol magnesium stearate mannitol microcrystalline cellulose purified water sodium laurilsulfate starch - ondansetron-drla tablets and ondansetron odt-drla tablets are indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron-drla tablets and ondansetron odt-drla tablets are also indicated for the prevention of post-operative nausea and vomiting.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - ondansetron 8mg;   - orodispersible tablet - 8 mg - active: ondansetron 8mg   excipient: aspartame colloidal silicon dioxide crospovidone microcrystalline cellulose and guar gum (avicel phce15) strawberry flavour (gurana powder) isopropyl alcohol magnesium stearate mannitol microcrystalline cellulose purified water sodium laurilsulfate starch - ondansetron-drla tablets and ondansetron odt-drla tablets are indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron-drla tablets and ondansetron odt-drla tablets are also indicated for the prevention of post-operative nausea and vomiting.

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - 2,4-db present as the dimethylamine salt - suspension concentrate - 2,4-db present as the dimethylamine salt phenoxy acids-2,4-db-amine active 500.0 g/l - herbicide